| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Wednesday - Dec 17, 2014 |
|||||||||
| Q2 FY15 | $2.14 | $2.22 | $11.94B | $12.39B |
NYSE |
||||
| Q2 FY15 | $0.69 | $0.68 | $9.60B | $9.46B |
NYSE |
||||
| Q2 FY15 | $0.80 | $0.76 | $4.71B | $4.54B |
NYSE |
||||
Jabil
JBL
|
Q1 FY15 | $0.55 | $0.47 | $4.55B | $3.89B |
NYSE |
|||
|
Worthington Industries
WOR
|
- | $0.55 | $0.66 | $871.01M | $1.02B |
NYSE |
|||
|
MillerKnoll
MLKN
|
- | $0.51 | $0.52 | $565.40M | - |
NASDAQ |
|||
|
Paymentus Holdings
PAY
|
- | $0.27 | - | $490.50M | - |
NYSE |
|||
|
Apogee Enterprises
APOG
|
- | $0.47 | $0.48 | $244.41M | $249.49M |
NASDAQ |
|||
|
Triumph Financial
TFIN
|
- | $0.17 | $0.25 | $25.30M | - |
NYSE |
|||
|
GT Biopharma
GTBP
|
- | -$22.79 K | - | $183K | - |
NASDAQ |
|||
|
Tenax Therapeutics
TENX
|
Q2 FY15 | -$4.48 K | -$3.50 | - | - |
NASDAQ |
|||
| Show 1 more companies | |||||||||
